Phase II study of liposome-complexed mitoxantrone in patients with advanced breast cancer

By Pestalozzi B.C.   Vass A.   Adam H.   Horber D.H.   Schwendener R.A.   Sauter C.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1024-1024

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Paclitaxel in Advanced Breast Cancer Resistant to Anthracyclines

By Fountzilas G.   Athanassiades A.   Giannakakis T.   Bafaloukos D.   Karakousis K.   Dombros N.   Kosmidis P.   Skarlos D.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Combination of Oral Idarubicin and Prednimustine in Advanced Breast Cancer: a Phase II Study

By Barnadas A.   Mendiola C.   Casado A.   Villar A.   Jimeno J.   Clerigue M.   Rosell R.   Diaz-Rubio E.   Cortes-Funes H.   Garci de Paredes M.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 312-315

Elsevier

Access to resources Recommend Favorite

Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group

By Masuda Norikazu   Taguchi Tetsuya   Nakayama Takahiro   Shiba Eiichi   Watatani Masahiro   Kurebayashi Junichi   Takatsuka Yuichi   Sakamoto Junichi   Noguchi Shinzaburo  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 989-995

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

By Kim Jong   Sohn Sang   Song Hong   Kwon Ki-Young   Do Young   Lee Kyung   Hyun Myung   Ryoo Hun   Bae Sung   Park Keon   Baek Jin   Lee Won   Chung Joo   Cho Goon   Sohn Chang-Hak   Jang Jung   Chung Ho   Yu Wansik  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 863-869

Springer Publishing Company

Access to resources Recommend Favorite